Disease Progression and Phasic Changes in Gene Expression in a Mouse Model of Osteoarthritis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Loeser, Richard F ^a   Olex, Amy L ^b   McNulty, Margaret A ^c   Carlson, Cathy S ^c   Callahan, Michael ^a   Ferguson, Cristin ^a   Fetrow, Jacquelyn S ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; COLLAGEN TYPE 3; FIBROMODULIN; GROWTH FACTOR; PROTEIN CREB3; SCLEROPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ERG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DEATH; COL3A1 GENE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DOWN REGULATION; FIBROMODULIN GENE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC SELECTION; HINDLIMB; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNEE MENISCUS; KNEE OSTEOARTHRITIS; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOPHYTE; PROLINE ARGININE RICH END LEUCINE RICH REPEAT PROTEIN GENE; RNA ISOLATION; TISSUE DISTRIBUTION; UPREGULATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; CLUSTER ANALYSIS; COLLAGEN TYPE III; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLYCOPROTEINS; JOINTS; MALE; MICE; MOLECULAR SEQUENCE ANNOTATION; OSTEOARTHRITIS; PROTEOGLYCANS;

EID: 84873860069     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054633     Document Type: Article

References (31)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, et al. (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II. Arthritis Rheum 58: 26-35.
2. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation--- United States, 2007-2009. MMWR Morb Mortal Wkly Rep 59: 1261-1265.
3. Blagojevic M, Jinks C, Jeffery A, Jordan KP, (2010) Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 18: 24-33.
4. Loeser RF, Goldring SR, Scanzello CR, Goldring MB, (2012) Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum 64: 1697-1707.
5. Glasson SS, Blanchet TJ, Morris EA, (2007) The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthritis Cartilage 15: 1061-1069.
6. Loeser RF, Olex A, McNulty MA, Carlson CS, Callahan M, et al. (2012) Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. Arthritis Rheum 64: 705-717.
7. McNulty MA, Loeser RF, Davey C, Callahan MF, Ferguson CM, Carlson CS, (2011) A comprehensive histological assessment of osteoarthritis lesions in mice. Cartilage 2: 354-363.
8. Chou JW, Paules RS, Bushel PR, (2005) Systematic variation normalization in microarray data to get gene expression comparison unbiased. J Bioinform Comput Biol 3: 225-241.
9. Olex AL, Hiltbold EM, Leng X, Fetrow JS, (2010) Dynamics of dendritic cell maturation are identified through a novel filtering strategy applied to biological time-course microarray replicates. BMC Immunol 11: 41.
10. Olex AL, Fetrow JS, (2011) SC(2)ATmd: a tool for integration of the figure of merit with cluster analysis for gene expression data. Bioinformatics 27: 1330-1331.
11. Yeung KY, Haynor DR, Ruzzo WL, (2001) Validating clustering for gene expression data. Bioinformatics 17: 309-318.
12. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
13. Huang DW, Sherman BT, Lempicki RA, (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13.
14. McNulty MA, Loeser RF, Davey C, Callahan MF, Ferguson CM, et al. (2012) Histopathology of naturally occurring and surgically induced osteoarthritis in mice. Osteoarthritis Cartilage 20: 949-956.
15. Kim JS, Ryoo ZY, Chun JS, (2007) Cytokine-like 1 (Cytl1) regulates the chondrogenesis of mesenchymal cells. J Biol Chem 282: 29359-29367.
16. Wolff DA, Stevenson S, Goldberg VM, (1992) S-100 protein immunostaining identifies cells expressing a chondrocytic phenotype during articular cartilage repair. J Orthop Res 10: 49-57.
17. Karlsson C, Dehne T, Lindahl A, Brittberg M, Pruss A, et al. (2010) Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 18: 581-592.
18. Embree MC, Kilts TM, Ono M, Inkson CA, Syed-Picard F, et al. (2010) Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis. Am J Pathol 176: 812-826.
19. Johnson K, Hashimoto S, Lotz M, Pritzker K, Goding J, et al. (2001) Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 44: 1071-1081.
20. Bengtsson E, Neame PJ, Heinegard D, Sommarin Y, (1995) The primary structure of a basic leucine-rich repeat protein, PRELP, found in connective tissues. J Biol Chem 270: 25639-25644.
21. Neame PJ, Tapp H, Azizan A, (1999) Noncollagenous, nonproteoglycan macromolecules of cartilage. Cell Mol Life Sci 55: 1327-1340.
22. Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, et al. (2002) A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem 277: 35532-35540.
23. Wang Q, Rozelle AL, Lepus CM, Scanzello CR, Song JJ, et al. (2011) Identification of a central role for complement in osteoarthritis. Nat Med 17: 1674-1679.
24. Grover J, Lee ER, Mounkes LC, Stewart CL, Roughley PJ, (2007) The consequence of PRELP overexpression on skin. Matrix Biol 26: 140-143.
25. Happonen KE, Furst CM, Saxne T, Heinegard D, Blom AM, (2012) PRELP protein inhibits the formation of the complement membrane attack complex. J Biol Chem 287: 8092-8100.
26. Aigner T, Bertling W, Stoss H, Weseloh G, von der Mark K, (1993) Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J Clin Invest 91: 829-837.
27. Fukui N, Ikeda Y, Ohnuki T, Tanaka N, Hikita A, et al. (2008) Regional differences in chondrocyte metabolism in osteoarthritis: A detailed analysis by laser capture microdissection. Arthritis Rheum 58: 154-163.
28. Young RD, Lawrence PA, Duance VC, Aigner T, Monaghan P, (2000) Immunolocalization of collagen types II and III in single fibrils of human articular cartilage. J Histochem Cytochem 48: 423-432.
29. Sharif M, Kirwan JR, Elson CJ, Granell R, Clarke S, (2004) Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum 50: 2479-2488.
30. Pottenger LA, Phillips FM, Draganich LF, (1990) The effect of marginal osteophytes on reduction of varus-valgus instability in osteoarthritic knees. Arthritis Rheum 33: 853-858.
31. Scharstuhl A, Glansbeek HL, Van Beuningen HM, Vitters EL, Van Der Kraan PM, et al. (2002) Inhibition of endogenous tgf-Beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J Immunol 169: 507-514.